Nomination Committee

The Annual General Meeting of 11 May 2021 decided to establish a Nomination Committee for the Annual General Meeting to be held in 2022. The full decision (including the Nomination Committee’s terms of reference) can be found in the minutes of the Annual General Meeting 2021, which can be found in the section Corporate Governance/General Meetings.

Nomination Committee in Senzime ahead of the 2022 Annual General Meeting

In accordance with the resolution at the Annual General Meeting of Senzime AB (publ) on May 11, 2021, the three largest shareholders on 1 September 2021 have appointed a Nomination Committee for the 2022 Annual General Meeting.

The three largest shareholders in terms of voting rights (considering owner groupings) as of September 1, 2021, are Adam Dahlberg and his family, AB Segulah and Handelsbanken Fonder. They have each appointed a member, as set out below, to form the Senzime Nomination Committee together with the Chairman of the Board.

Adam Dahlberg (Chairman)
Gabriel Urwitz, AB Segulah
Malin Björkmo, Handelsbanken Fonder
Philip Siberg, Chairman of the Board of Senzime AB (publ)

The shareholders who have appointed members to the Nomination Committee represent approximately 29 percent of the voting rights of all shares in the company.

Shareholders who wish to submit proposals to the Nomination Committee may do so by e-mail to

Explore our patient monitoring solutions

Get product details

How can Senzime’s products help to eliminate in-hospital complications?
Contact us to discuss your needs or schedule a product demo.